Federal contractor profile
Auravax Therapeutics, INC.
Houston, TX · Not a small business · Part of Auravax Therapeutics INC.
UEI PAN3ZK2YLAL2 · CAGE 969E2
Contracts won
1
since Sep 2024 · last Sep 2024
Total value
$750K
including options
Buying offices
1
government offices it sold to
Usual competition
1 offer
100% of its wins had one offer
Who it sells to
Barda - Aspr / Daappo / Barda Dcma
Administration For Strategic Preparedness And Response · 1 win · $750K
What it wins
Health R&D Services; Health Care Services; R&D Administrative Expenses
PSC AN14 · 1 win · $750K
Ending in the next 12 months
Contracts that end soon are usually re-bid. These could be openings for a competitor.
The Overall Objective Of This Contract Is To Assess The Ability Of Auravax Therapeutics? (Auravax) Novel Mucosal Adjuvant Nanosting-002, Together With Influenza Live Attenuated Virus (Lav) Created With Codagenix Novel Synthetic Attenuated Virus Engin
Barda - Aspr / Daappo / Barda Dcma · ends Dec 2026 · $750K
Is this your company?
Claim this profile free, and see the open contracts that fit what you win: who else bids, what the government paid last time, and what to bid.
From federal contract award records (SAM.gov), base awards over $10K since fiscal year 2024, updated daily. Values include options where reported.
ZukoBid is an independent service, not affiliated with or endorsed by any government agency. Figures come from public records and may contain errors; always check the official listing before you bid. Spotted an error about Auravax Therapeutics, INC.? Request a correction.